Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 17 for:    A Phase II Trial of Stereotactic Ablative Body Radiation Therapy (SABR) for Patients with Primary Renal Cell Carcinoma (RCC)
Previous Study | Return to List | Next Study

Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02141919
Recruitment Status : Active, not recruiting
First Posted : May 20, 2014
Last Update Posted : October 19, 2020
Sponsor:
Information provided by (Responsible Party):
Raquibul Hannan, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 2021
Estimated Study Completion Date : December 2025